I Expect Crispr Therapeutics To Break Out As 2026 Revenue Exceeds Expectations [Seeking Alpha]
CRISPR Therapeutics AG - Common Shares (CRSP)
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
nasdaq.com/symbol/crsp/real-time
Company Research
Source: Seeking Alpha
Analysts are underestimating the Casgevy revenue ramp. CRSP now trades at the low end of its 4-year range, despite risk mitigation, a very promising pipeline, and a robust balance sheet, creating a compelling entry point. Casgevy's efficacy is very strong, with 90% response rates, but uptake has lagged due to burdensome preconditioning and patient concerns. I maintain a Strong Buy rating, citing imminent revenue growth, pipeline diversification, and strategic partnerships with Vertex, Sirius, and Eli Lilly. piyaset/iStock via Getty Images Crispr Therapeutics AG ( CRSP ), headquartered in Zug, Switzerland, is a biopharmaceutical company with a mission to "create transformative gene-based medicines for serious human diseases." With Vertex Pharmaceuticals ( VRTX ), they have the first This article was written by Analyst's Disclosure: I/we have a beneficial long position in the shares of CRSP, VRTX either through stock ownership, options, or other derivatives. I wrote this a
Show less
Read more
Impact Snapshot
Event Time:
CRSP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRSP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRSP alerts
High impacting CRISPR Therapeutics AG - Common Shares news events
Weekly update
A roundup of the hottest topics
CRSP
News
- CRISPR Therapeutics AG (CRSP) Rises Higher Than Market: Key Facts [Yahoo! Finance]Yahoo! Finance
- CRISPR (CRSP) Rated Overweight on Gene Editing Growth [Yahoo! Finance]Yahoo! Finance
- Is CRISPR Therapeutics (CRSP) Attractive After Recent Share Price Pullback? [Yahoo! Finance]Yahoo! Finance
- CRISPR Therapeutics (CRSP) was upgraded by Truist Financial Corporation to "strong-buy".MarketBeat
- Learn From The Leaders: Biotech Stock Research On Seeking Alpha | Ed Ingham's 6-Tab Method [Seeking Alpha]Seeking Alpha
CRSP
Earnings
- 2/12/26 - Miss
CRSP
Sec Filings
- 4/2/26 - Form PRE
- 3/24/26 - Form 4
- 3/24/26 - Form 4
- CRSP's page on the SEC website